InsidersTradesSigma
Follow the 沃华医药 stock price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 沃华医药 has logged 5 public disclosures. Market capitalisation: €3.6bn. The latest transaction was filed on 11 June 2026 (Sale). Among the most active insiders: 张戈. Every trade is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€650,114
5 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,938 of 28,856 companies
62.7
score / 100
Value41
Quality85
FCF yld3.5%
Earn yld2.6%
EV/EBITDA27.2x
ROE16%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 June 2026
Declarations5 total
5 of 5 declarations
About 沃华医药
沃华医药 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.